BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25179425)

  • 21. 5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition.
    Cazarin JM; Coelho RG; Hecht F; Andrade BM; Carvalho DP
    Thyroid; 2016 Jul; 26(7):933-42. PubMed ID: 27121619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of pancreatic cancer stem cell characteristics by α-Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog.
    Ma Y; Yu W; Shrivastava A; Srivastava RK; Shankar S
    J Cell Mol Med; 2019 Apr; 23(4):2719-2730. PubMed ID: 30712329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genistein induced anticancer effects on pancreatic cancer cell lines involves mitochondrial apoptosis, G
    Bi YL; Min M; Shen W; Liu Y
    Phytomedicine; 2018 Jan; 39():10-16. PubMed ID: 29433670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Taurolidine induces apoptosis of murine melanoma cells in vitro and in vivo by modulation of the Bcl-2 family proteins.
    Sun BS; Wang JH; Liu LL; Gong SL; Redmond HP
    J Surg Oncol; 2007 Sep; 96(3):241-8. PubMed ID: 17469118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
    Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
    Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
    Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of taurolidine, a novel antineoplastic agent, on human malignant mesothelioma.
    Nici L; Monfils B; Calabresi P
    Clin Cancer Res; 2004 Nov; 10(22):7655-61. PubMed ID: 15569998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of JDP2 and ATF2 on the epithelial-mesenchymal transition of human pancreatic cancer cell lines.
    Xu Y; Liu Z; Guo K
    Pathol Oncol Res; 2012 Jul; 18(3):571-7. PubMed ID: 22109562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro treatment of carcinoma cell lines with pancreatic (pro)enzymes suppresses the EMT programme and promotes cell differentiation.
    Perán M; Marchal JA; García MA; Kenyon J; Tosh D
    Cell Oncol (Dordr); 2013 Jul; 36(4):289-301. PubMed ID: 23677639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting Epithelial-Mesenchymal Transition for Identification of Inhibitors for Pancreatic Cancer Cell Invasion and Tumor Spheres Formation.
    Polireddy K; Dong R; McDonald PR; Wang T; Luke B; Chen P; Broward M; Roy A; Chen Q
    PLoS One; 2016; 11(10):e0164811. PubMed ID: 27764163
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Byer B; Schlein LJ; Rose B; Séguin B
    Can J Vet Res; 2020 Apr; 84(2):115-123. PubMed ID: 32255906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of taurolidine on the growth of CC531 coloncarcinoma cells in vitro and in a laparoscopic animal model in rats.
    Nestler G; Schulz HU; Schubert D; Krüger S; Lippert H; Pross M
    Surg Endosc; 2005 Feb; 19(2):280-4. PubMed ID: 15870965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of MIST1 reverses the epithelial-mesenchymal transition and reduces the tumorigenicity of pancreatic cancer cells via the Snail/E-cadherin pathway.
    Li X; Chen H; Liu Z; Ye Z; Gou S; Wang C
    Cancer Lett; 2018 Sep; 431():96-104. PubMed ID: 29859299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of Fas-ligand-mediated programmed cell death by taurolidine.
    Stendel R; Scheurer L; Stoltenburg-Didinger G; Brock M; Möhler H
    Anticancer Res; 2003; 23(3B):2309-14. PubMed ID: 12894508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor necrosis factor-α (TNF-α) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma.
    Techasen A; Namwat N; Loilome W; Bungkanjana P; Khuntikeo N; Puapairoj A; Jearanaikoon P; Saya H; Yongvanit P
    Med Oncol; 2012 Dec; 29(5):3083-91. PubMed ID: 22903530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple effects of digoxin on subsets of cancer-associated genes through the alternative splicing pathway.
    Lu GY; Liu ST; Huang SM; Chang YL; Lin WS
    Biochimie; 2014 Nov; 106():131-9. PubMed ID: 25193633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Taurolidine: a novel anti-neoplastic agent induces apoptosis of osteosarcoma cell lines.
    Walters DK; Muff R; Langsam B; Gruber P; Born W; Fuchs B
    Invest New Drugs; 2007 Aug; 25(4):305-12. PubMed ID: 17458504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dexamethasone inhibits hypoxia-induced epithelial-mesenchymal transition in colon cancer.
    Kim JH; Hwang YJ; Han SH; Lee YE; Kim S; Kim YJ; Cho JH; Kwon KA; Kim JH; Kim SH
    World J Gastroenterol; 2015 Sep; 21(34):9887-99. PubMed ID: 26379394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclooxygenase-2 expression is related to the epithelial-to-mesenchymal transition in human colon cancers.
    Jang TJ; Jeon KH; Jung KH
    Yonsei Med J; 2009 Dec; 50(6):818-24. PubMed ID: 20046424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epithelial to mesenchymal transition is associated with rapamycin resistance.
    Holder AM; Akcakanat A; Adkins F; Evans K; Chen H; Wei C; Milton DR; Li Y; Do KA; Janku F; Meric-Bernstam F
    Oncotarget; 2015 Aug; 6(23):19500-13. PubMed ID: 25944619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.